*<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0031539#s3" target="_blank">Results</a> are expressed as % of vehicle control (mean ± SEM).</p
<p>*Data expressed as the mean of IC<sub>50</sub> (μM) ± SD, n = 3 independent MTT assays.</p><p>Eff...
<p>Cells were treated with different concentrations of paclitaxel, cisplatin, and doxorubicin and/or...
<p>HMEC-1 cells were treated for 24 h with nothing (Control), vehicle (0.04% v/v DMSO), or 100 µM NC...
#<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0031539#s3" target="_blank...
<p>Cells were treated with MSA, paclitaxel, or the combination for 48 hr, and then subjected to anal...
<p>(<b>A</b>) Tumor growth curve. Data are presented as tumor volumes in each group (n = 6 tumors/gr...
<p>Cells were treated with 3.2 or 4 µM MSA, 10 nM paclitaxel, or the combinations for 72 hr. Live ce...
<p>Relative cell viability upon treatment with paclitaxel in increasing concentrations (0, 2.5, 5, 1...
<p>HNGC-2 cells were treated for 24 h with lomustine, carmustine, UCN-01, oxaliplatin, temozolomide,...
<p>These data represent the means ± SEM. Significantly different from control (*) or combination of ...
<p>(<b>A</b>) TUNEL staining. Data are presented as mean number of TUNEL-positive cells in each imag...
<p>(A) Proliferation of HUVEC treated with vehicle control, with different doses of MPs or MP-treate...
<p>(A) Effect of knockdown of <i>RAP1A</i> and <i>STAT3</i> expression by siRNA on cell viability in...
Cell viability test performed by the MTS assay (measures mitochondrial activity, see “Materials and ...
<p>Cells were pre-treated with 50 µM pan-caspase inhibitor Z-VAD-FMK prior to treatment with 3.2 µM ...
<p>*Data expressed as the mean of IC<sub>50</sub> (μM) ± SD, n = 3 independent MTT assays.</p><p>Eff...
<p>Cells were treated with different concentrations of paclitaxel, cisplatin, and doxorubicin and/or...
<p>HMEC-1 cells were treated for 24 h with nothing (Control), vehicle (0.04% v/v DMSO), or 100 µM NC...
#<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0031539#s3" target="_blank...
<p>Cells were treated with MSA, paclitaxel, or the combination for 48 hr, and then subjected to anal...
<p>(<b>A</b>) Tumor growth curve. Data are presented as tumor volumes in each group (n = 6 tumors/gr...
<p>Cells were treated with 3.2 or 4 µM MSA, 10 nM paclitaxel, or the combinations for 72 hr. Live ce...
<p>Relative cell viability upon treatment with paclitaxel in increasing concentrations (0, 2.5, 5, 1...
<p>HNGC-2 cells were treated for 24 h with lomustine, carmustine, UCN-01, oxaliplatin, temozolomide,...
<p>These data represent the means ± SEM. Significantly different from control (*) or combination of ...
<p>(<b>A</b>) TUNEL staining. Data are presented as mean number of TUNEL-positive cells in each imag...
<p>(A) Proliferation of HUVEC treated with vehicle control, with different doses of MPs or MP-treate...
<p>(A) Effect of knockdown of <i>RAP1A</i> and <i>STAT3</i> expression by siRNA on cell viability in...
Cell viability test performed by the MTS assay (measures mitochondrial activity, see “Materials and ...
<p>Cells were pre-treated with 50 µM pan-caspase inhibitor Z-VAD-FMK prior to treatment with 3.2 µM ...
<p>*Data expressed as the mean of IC<sub>50</sub> (μM) ± SD, n = 3 independent MTT assays.</p><p>Eff...
<p>Cells were treated with different concentrations of paclitaxel, cisplatin, and doxorubicin and/or...
<p>HMEC-1 cells were treated for 24 h with nothing (Control), vehicle (0.04% v/v DMSO), or 100 µM NC...
DOI
Add to ORKG